Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Rowe

Showing results (151-160 of 205) with videos related to

Pageof 21
Sort By:
Leukemia|December 9, 1998
Biologic heterogeneity in Philadelphia chromosome-positive acute leukemia with myeloid morphology: the Eastern Cooperative Oncology Group experienceE Paietta, J Racevskis, J M Bennett, et al.
Leukemia|November 1, 1992
Post-remission therapy in adults with acute myelogenous leukemia: the Eastern Cooperative Oncology Group (ECOG) experienceJ M Rowe, J W Andersen, P A Cassileth, et al.
American Journal of Hematology|January 1, 2003
Familial severe congenital neutropenia associated with infantile osteoporosis: a new entityR Elhasid, L C Hofbauer, S Ish-Shalom, et al.
Leukemia|May 10, 2000
Immune and hematopoietic reconstitution after transplantation of cord blood progenitor cells: case report and review of the literatureR Elhasid, M W Ben Arush, S Pollack, et al.
Cancer|February 19, 1999
Mitoxantrone, etoposide, and cytarabine plus cyclosporine for patients with relapsed or refractory acute myeloid leukemia: an Eastern Cooperative Oncology Group pilot studyM S Tallman, S Lee, B I Sikic, et al.
Pediatric Hematology and Oncology|February 9, 2002
Therapeutic monitoring of busulfan in pediatric bone marrow transplantationN Krivoy, E Hoffer, A Tabak, et al.
American Journal of Clinical Oncology|December 1, 1991
Treatment of advanced refractory lymphomas with a combination of carmustine, bleomycin, teniposide, dexamethasone, and cisplatin (the BBVDD regimen). An ECOG pilot studyA S Spiers, J H Weens, J M Rowe, et al.
Haematology and Blood Transfusion|January 1, 1990
Mitoxantrone and etoposide in patients with relapsed and refractory acute nonlymphocytic leukemiaJ M Rowe, J J Mazza, J D Hines, et al.
Leukemia|August 15, 2000
Duration of second complete remission compared with first complete remission in patients with acute myeloid leukemia. Eastern Cooperative Oncology GroupS Lee, M S Tallman, M M Oken, et al.
British Journal of Haematology|March 6, 1998
Acute myeloid leukaemia expressing the leucocyte integrin CD11b-a new leukaemic syndrome with poor prognosis: result of an ECOG database analysis. Eastern Cooperative Oncology GroupE Paietta, J Andersen, J Yunis, et al.
Pageof 21

Showing results (151-160 of 205) with videos related to

Sort By:
Pageof 21
Leukemia|December 9, 1998
Biologic heterogeneity in Philadelphia chromosome-positive acute leukemia with myeloid morphology: the Eastern Cooperative Oncology Group experienceE Paietta, J Racevskis, J M Bennett, et al.
Leukemia|November 1, 1992
Post-remission therapy in adults with acute myelogenous leukemia: the Eastern Cooperative Oncology Group (ECOG) experienceJ M Rowe, J W Andersen, P A Cassileth, et al.
American Journal of Hematology|January 1, 2003
Familial severe congenital neutropenia associated with infantile osteoporosis: a new entityR Elhasid, L C Hofbauer, S Ish-Shalom, et al.
Leukemia|May 10, 2000
Immune and hematopoietic reconstitution after transplantation of cord blood progenitor cells: case report and review of the literatureR Elhasid, M W Ben Arush, S Pollack, et al.
Cancer|February 19, 1999
Mitoxantrone, etoposide, and cytarabine plus cyclosporine for patients with relapsed or refractory acute myeloid leukemia: an Eastern Cooperative Oncology Group pilot studyM S Tallman, S Lee, B I Sikic, et al.
Pediatric Hematology and Oncology|February 9, 2002
Therapeutic monitoring of busulfan in pediatric bone marrow transplantationN Krivoy, E Hoffer, A Tabak, et al.
American Journal of Clinical Oncology|December 1, 1991
Treatment of advanced refractory lymphomas with a combination of carmustine, bleomycin, teniposide, dexamethasone, and cisplatin (the BBVDD regimen). An ECOG pilot studyA S Spiers, J H Weens, J M Rowe, et al.
Haematology and Blood Transfusion|January 1, 1990
Mitoxantrone and etoposide in patients with relapsed and refractory acute nonlymphocytic leukemiaJ M Rowe, J J Mazza, J D Hines, et al.
Leukemia|August 15, 2000
Duration of second complete remission compared with first complete remission in patients with acute myeloid leukemia. Eastern Cooperative Oncology GroupS Lee, M S Tallman, M M Oken, et al.
British Journal of Haematology|March 6, 1998
Acute myeloid leukaemia expressing the leucocyte integrin CD11b-a new leukaemic syndrome with poor prognosis: result of an ECOG database analysis. Eastern Cooperative Oncology GroupE Paietta, J Andersen, J Yunis, et al.
Pageof 21